Douglas Pagán
Director of Finance/CFO chez Jnana Therapeutics, Inc.
Profil
Douglas W.
Pagán is currently the Chief Operating & Financial Officer at Jnana Therapeutics, Inc. He previously worked as a Finance Director at Biogen, Inc., an Independent Director at Alaunos Therapeutics, Inc., a Manager-International Treasury at Bristol Myers Squibb Co., a Senior Engineer at Johnson & Johnson, a Vice President-Finance at Acceleron Pharma, Inc., the Chief Financial Officer at Dicerna Pharmaceuticals, Inc., a Principal at JPMorgan Investment Bank, the Chief Financial & Accounting Officer at Paratek Pharmaceuticals, Inc., and the Chief Financial Officer & Secretary at KSQ Therapeutics, Inc. Pagán received his undergraduate degree from Princeton University in 1993 and his MBA from Columbia Business School in 2001.
Postes actifs de Douglas Pagán
Sociétés | Poste | Début |
---|---|---|
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Director of Finance/CFO | 26/04/2022 |
Anciens postes connus de Douglas Pagán
Sociétés | Poste | Fin |
---|---|---|
ALAUNOS THERAPEUTICS, INC. | Director/Board Member | 18/09/2020 |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Director of Finance/CFO | 31/05/2020 |
PARATEK PHARMACEUTICALS, INC. | Director of Finance/CFO | 05/04/2019 |
ACCELERON PHARMA INC. | Director of Finance/CFO | 01/12/2014 |
DICERNA PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Formation de Douglas Pagán
Princeton University | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 5 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
JOHNSON & JOHNSON | Health Technology |
BIOGEN INC. | Health Technology |
ALAUNOS THERAPEUTICS, INC. | Health Technology |
PARATEK PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Health Technology |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Health Technology |
JPMorgan Investment Bank
JPMorgan Investment Bank Investment Banks/BrokersFinance JPMorgan Investment Bank operates as an investment banking firm. The company is headquartered in Houston, TX. | Finance |